Resonance Specialties Limited carries a market capitalization of 1.54B, placing it among publicly traded companies globally. Its enterprise value stands at 799.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.54B |
| Enterprise Value | 799.59M |
Resonance Specialties Limited currently has 11.54M shares outstanding.
| Shares Outstanding | 11.54M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Resonance Specialties Limited trades at a trailing price-to-earnings ratio of 8.65. The price-to-sales ratio is 1.00, and the price-to-book ratio stands at 7.79.
| PE Ratio | 8.65 |
| PS Ratio | 1.00 |
| PB Ratio | 7.79 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Resonance Specialties Limited trades at an EV/EBITDA multiple of 6.31 and an EV/FCF ratio of 450.09. The EV/Sales ratio of 0.89 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.31 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.89 |
| EV / EBITDA | 6.31 |
| EV / EBIT | 6.31 |
| EV / FCF | 450.09 |
Resonance Specialties Limited maintains a current ratio of 4.12, meaning it holds 4.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.06, indicating elevated leverage, while an interest coverage ratio of 52.69 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.12 |
| Quick Ratio | 0.75 |
| Debt / Equity | 3.06 |
| Debt / EBITDA | 0.18 |
| Interest Coverage | 52.69 |
Resonance Specialties Limited posts a return on equity of 28.81 and a return on invested capital of 13.03.
| Return on Equity (ROE) | 28.81 |
| Return on Assets (ROA) | 12.37 |
| Return on Invested Capital (ROIC) | 13.03 |
| Return on Capital Employed (ROCE) | 27.21 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.31 |
Over the trailing twelve months, Resonance Specialties Limited has paid 36.78M in income taxes, reflecting an effective tax rate of 26.13.
| Income Tax | 36.78M |
| Effective Tax Rate | 26.13 |
Resonance Specialties Limited's stock has gained approximately 11.76471% over the past 52 weeks. The 50-day moving average sits at 124.25, while the 200-day moving average is 104.04.
| Beta (5Y) | N/A |
| 52-Week Price Change | 11.76471% |
| 50-Day Moving Average | 124.25 |
| 200-Day Moving Average | 104.04 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Resonance Specialties Limited generated 902.48M in revenue and converted that into 103.96M in net income, yielding earnings per share of 9.01. EBITDA reached 126.72M, while operating income came in at 126.72M.
| Revenue | 902.48M |
| Gross Profit | 506.92M |
| Operating Income | 126.72M |
| Pretax Income | 140.74M |
| Net Income | 103.96M |
| EBITDA | 126.72M |
| EBIT | 126.72M |
| Earnings Per Share (EPS) | 9.01 |
Resonance Specialties Limited holds 121.78M in cash and equivalents against 22.38M in total debt, resulting in a net debt position of 18.80M. Total book value stands at 115.44M, with working capital of 506.56M providing operational flexibility.
| Cash & Cash Equivalents | 121.78M |
| Total Debt | 22.38M |
| Net Debt | 18.80M |
| Equity (Book Value) | 115.44M |
| Book Value Per Share | 10.01 |
| Working Capital | 506.56M |
Resonance Specialties Limited operates with a gross margin of 56.17, reflecting its pricing power and cost economics. The operating margin of 14.04 and net profit margin of 11.52 provide insight into operational efficiency.
| Gross Margin | 56.17 |
| Operating Margin | 14.04 |
| Pretax Margin | 15.59 |
| Profit Margin | 11.52 |
| EBITDA Margin | 14.04 |
Resonance Specialties Limited posts an Altman Z-Score of 4.91, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.91 |